Reactive arthritis after COVID-19
Open Access
- 2 March 2021
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 14 (3), e241375
- https://doi.org/10.1136/bcr-2020-241375
Abstract
A previously healthy 53-year-old man was hospitalised for 12 days due to COVID-19 with shortness of breath. A few days after discharge from hospital, the patient developed fever and severe pain in several joints in the lower extremities. The pain was so severe that the patient was unable to stand on his feet. Synovial fluid from the right-side knee contained a high number of polynuclear cells and a few mononuclear cells. Microscopy, culture and PCR tests for bacterial infection were all negative. Furthermore, the patient tested negative for rheumatoid factor, anti-cyclic citrullinated peptide and human leukocyte antigen (HLA)-B27. Thus, the condition was compatible with reactive arthritis. The condition improved markedly after a few days’ treatment with non-steroid anti-inflammatory drugs and prednisolone.Keywords
This publication has 10 references indexed in Scilit:
- Dexamethasone in Hospitalized Patients with Covid-19The New England Journal of Medicine, 2021
- The first reactive arthritis case associated with COVID-19Journal of Medical Virology, 2021
- Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine, 2020
- Reactive arthritis after COVID-19 infectionRMD Open, 2020
- A Case of Reactive Arthritis Secondary to Coronavirus Disease 2019 InfectionJCR: Journal of Clinical Rheumatology, 2020
- Extrapulmonary manifestations of COVID-19Nature Medicine, 2020
- Case of acute arthritis following SARS-CoV-2 infectionAnnals Of The Rheumatic Diseases, 2020
- Reactive Arthritis: Treatment Challenges and Future PerspectivesCurrent Rheumatology Reports, 2020
- Bacterial septic arthritis in adultsThe Lancet, 2010